Margaret Mitchell: Unfiltered

Eli Lilly's new once-daily oral GLP-1, Foundayo, is now on telehealth platform Ro, offering a convenient, needle-free alternative to injectable drugs.

OncoC4 begins a landmark trial for ONC-841, a drug targeting immune cells in the brain, offering a new front in the fight against Alzheimer's disease.

Kia unveils an ambitious roadmap for exponential growth, detailing a massive investment in EVs, hybrids, autonomous tech, and robotics to reshape its future.

A new app lets users bet on viral videos, raising over $1M to financialize social media. But does it create a new economy or a new set of risks?

As uranium prices soar, one explorer uses advanced 3D modeling and AI to unlock new discovery potential in Canada's richest uranium district.

With a new fund and a key hire, the PE firm signals an aggressive push to dominate the burgeoning market for AI and cybersecurity infrastructure services.

Douglas Elliman hires luxury strategist Areeje Akhtar Oriol, signaling a tech-driven push to redefine its platform for agents and high-net-worth clients.

Fintech launches a new platform to fix scan-based trading with AI-driven data and automated payments, promising better profits and partnerships for retailers.

Former DARPA and NIWC Pacific leader Dr. Patrick Sims joins EverGlade, bringing insider expertise to the high-stakes world of federal R&D funding.

With its lead cancer drug advancing and a strong balance sheet, Nurix will detail its vision for protein degradation at a key investor conference.

The Scientology Network is airing a global anti-drug marathon, but health experts are questioning the science and motives behind the massive campaign.

A new IDC MarketScape report positions HighByte as a leader in the emerging Industrial DataOps space, validating its pivotal role in manufacturing's AI future.

Michigan's Dort Financial Credit Union partners with Spiral to launch a new digital savings tool, blending gamification with its community-first mission.

TriNetX's acquisition of Zetta Genomics' XetaBase platform promises to accelerate research by integrating genomic and clinical data on a global scale.

GTA municipalities could save millions and slash emissions by using recycled road materials, but outdated local policies are blocking the path forward.

Amidst rising costs and market volatility, Centene appoints two new Group Presidents. Is this strategic overhaul the key to future growth and profitability?

Central 1 elects six new directors under a revamped governance model, reducing board size and shifting voting power in a move watched by the industry.

Demand The Limits Injury Attorneys' client-first model fuels explosive growth, earning a top spot on Inc.'s prestigious Southeast list despite new hurdles.

Following a strong earnings report, Rezolve AI's CEO Dan Wagner has acquired 9 million shares, signaling deep insider confidence in its vision.

A Canadian company has earned top marks from healthcare professionals for its clinically proven approach to preventing UTIs. Here’s what sets Utiva apart.